Fig. 4.
Immunoglobulin (Ig)E and IgG autoimmune response to the low‐affinity IgE receptor (FcεRII) in healthy controls and patient subgroups divided based on clinical response to omalizumab. Horizontal lines represent medians.
Immunoglobulin (Ig)E and IgG autoimmune response to the low‐affinity IgE receptor (FcεRII) in healthy controls and patient subgroups divided based on clinical response to omalizumab. Horizontal lines represent medians.